Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClotFoam in liver surgery
NCT02264730Phase 1Unknown
- Sponsor
- Biomedica Management Corporation
- Start
- Jul 2014
- Primary completion
- Jan 2015
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ClotFoam, sponsored by Biomedica Management Corporation. Primary endpoint: Control mild-to-moderate bleeding during surgery at 12 weeks. Status: unknown.
02
Drugs
ClotFoam
Beyond the preview
Go deeper on NCT02264730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264730.